Conflict of interest: Dr. Lee: speaker's bureau-BSCI, BMS, Daiichi Sankyo, Merck, and Novartis. Dr. Biondi-Zoccai: consulted for Boston Scientific, Cordis, Invatec, and Medtronic; lectured for Medtronic. Dr. Aragon: speaker's bureau-Abbott Vascular.
Coronary Artery Disease
Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function†
Article first published online: 8 APR 2011
Copyright © 2010 Wiley-Liss, Inc.
Catheterization and Cardiovascular Interventions
Volume 77, Issue 7, pages 945–951, 1 June 2011
How to Cite
Lee, M. S., Yang, T., Biondi-Zoccai, G., Sillano, D., Cerrato, E., Tarantini, G., Xhaxho, J., Aragon, J. and Sheiban, I. (2011), Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function. Cathet. Cardiovasc. Intervent., 77: 945–951. doi: 10.1002/ccd.22777
- Issue published online: 19 MAY 2011
- Article first published online: 8 APR 2011
- Accepted manuscript online: 7 SEP 2010 12:44PM EST
- Manuscript Accepted: 12 AUG 2010
- Manuscript Received: 20 JUN 2010
This article has been cited by: